Arcus Biosciences (RCUS) Other Operating Expenses (2020 - 2024)
Arcus Biosciences' (RCUS) quarterly Other Operating Expenses came in at $20.0 million in Q1 2024, up 8164.52% quarter-over-quarter from -$248000.0 in Q4 2020.
Arcus Biosciences (RCUS) Other Operating Expenses (2020 - 2024) Analysis & Trends
Arcus Biosciences' Other Operating Expenses history runs 2 years deep, the most recent figure standing at $20.0 million for Q1 2024.
- On a quarterly basis, Other Operating Expenses changed N/A year-over-year to $20.0 million in Q1 2024; TTM through Dec 2024 was $20.0 million, a N/A change from a year earlier, with the FY2024 full-year figure at $20.0 million, changed N/A from the prior year.
- Other Operating Expenses advanced to $20.0 million in Q1 2024 per RCUS's latest filing, from -$248000.0 in the prior quarter.
- Across five years, Other Operating Expenses topped out at $20.0 million in Q1 2024 and bottomed at -$248000.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Arcus Biosciences | 3.73 Bn | 2.90 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 20.00 Mn |
| Dec 31, 2020 | -248,000.00 |